1 / 15

F RANTZ M EDICAL

F RANTZ M EDICAL. HOYA & Min kone er Norsk & 30 years experience with transatlantic tech transfer. F RANTZ M EDICAL. F RANTZ M EDICAL. Who: Frantz Medical Group / Ventures What: Biotech – devices and diagnostics Why: Growth areas with high return (despite high risk)

michel
Download Presentation

F RANTZ M EDICAL

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FRANTZ MEDICAL

  2. HOYA&Min kone er Norsk&30 years experience with transatlantic tech transfer FRANTZMEDICAL

  3. FRANTZMEDICAL • Who: • Frantz Medical Group / Ventures • What: • Biotech – devices and diagnostics • Why: • Growth areas with high return (despite high risk) • How: Source of new technology • Academic / clinical collaborations • Transatlantic access to I.P., markets & capital

  4. FRANTZMEDICAL FRANTZ MEDICAL GROUP ORIGIN: 1976 U.S. CT Scanner > M.E., French pumps > U.S. EVOLVED: turn-key R&D manufacturing GROWTH: internal I.P. licensing JV (academic/clinical, industry)

  5. FRANTZ MEDICAL VENTURES Unique VC model: In-house science operating company support “Co-venturer of Choice” to established VCs financial group FRANTZMEDICAL

  6. FRANTZMEDICAL FRANTZ MEDICAL VENTURES PrognostiX

  7. Areas of experience Devices, diagnostics - therapeutic enablers, crossovers – device/drugs Growth therapies Cardiovascular, orthopedics, metabolic, female medicine, …. Comfort with full spectrum of stages Start-up (FMG) >> middle level (FMV) FRANTZMEDICAL FOCUS

  8. FRANTZMEDICAL FUNDAMENTAL CRITERIA Proprietary technology that serves an established or emerging need in a differentiated manner

  9. Projected ROI Market Opportunity Market Size Strategic Partner Intellectual Property Time to Market Stage of Development Use of funds Negotiations/Deal Management Other Investors Scientific Support FMG Advocates Comments FRANTZMEDICAL Litmus Test criteria

  10. FRANTZMEDICAL SOURCE In-house inventions Licenses Joint Ventures: • academic/clinical institutions • industrial partners

  11. Academic/clinical institutions – long-term relationships Technion – FrantzTech Cleveland Clinic – Frantz BioMarkers, Merlot Orthopaedics) Access to wide range of technology, technologyplatforms, complementary resources: Clinical perspective Science Testing FRANTZMEDICAL MOST PROLIFIC

  12. Investments and Alliances:The Cleveland Clinic Foundation

  13. FRANTZMEDICAL FRANTZ BIOMARKERS

  14. FRANTZMEDICAL TRANSATLANTIC COLLABORATION Experience France, Germany, Italy, U.K., Israel, Ukraine & NORWAY Common themes/issues: • Cultural > business practices, risk profile • I.P. – patenting, specific vs. platform

  15. FRANTZMEDICAL NORWEGIAN PGS experience:applied American model to Norwegian technology (Ramform vessel design) • access to capital • motivational methods: stock options • = “Cowboys” Issues: conflicts over practices • GAAP • Foreign business practices, Sarbanes-Oxley VC approach in Norway….

More Related